Heparin administration in acute coronary insufficiency. Its value in the initial stages of treatment.
D000284:Administration, Oral; D000368:Aged; D001219:Aspartate Aminotransferases / Q000097:blood; D003327:Coronary Disease / Q000188:drug therapy* / Q000201:enzymology; D003402:Creatine Kinase / Q000097:blood; D004562:Electrocardiography; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control; D013997:Time Factors; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D014859:Warfarin; D006493:Heparin; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase